Parker AR - Search Results

1

LigAmp for sensitive detection of single-nucleotide differences.

Shi C, Eshleman SH, Jones D, Fukushima N, Hua L, Parker AR, Yeo CJ, Hruban RH, Goggins MG, Eshleman JR. Shi C, et al. Among authors: parker ar. Nat Methods. 2004 Nov;1(2):141-7. doi: 10.1038/nmeth713. Epub 2004 Oct 21. Nat Methods. 2004. PMID: 15782177

2

Human MutY: gene structure, protein functions and interactions, and role in carcinogenesis.

Parker AR, Eshleman JR. Parker AR, et al. Cell Mol Life Sci. 2003 Oct;60(10):2064-83. doi: 10.1007/s00018-003-3053-4. Cell Mol Life Sci. 2003. PMID: 14618256 Free PMC article. Review.

3

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.

Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins M. Iacobuzio-Donahue CA, et al. Am J Pathol. 2003 Apr;162(4):1151-62. doi: 10.1016/S0002-9440(10)63911-9. Am J Pathol. 2003. PMID: 12651607 Free PMC article.

4

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours.

Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Berman DM, et al. Among authors: parker ar. Nature. 2003 Oct 23;425(6960):846-51. doi: 10.1038/nature01972. Epub 2003 Sep 14. Nature. 2003. PMID: 14520411

5

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio-Donahue CA, Eshleman JR, Goggins M. Sato N, et al. Among authors: parker ar. Oncogene. 2005 Jan 27;24(5):850-8. doi: 10.1038/sj.onc.1208050. Oncogene. 2005. PMID: 15592528

6

Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair.

Parker AR, Sieber OM, Shi C, Hua L, Takao M, Tomlinson IP, Eshleman JR. Parker AR, et al. Carcinogenesis. 2005 Nov;26(11):2010-8. doi: 10.1093/carcin/bgi166. Epub 2005 Jun 29. Carcinogenesis. 2005. PMID: 15987719

7

Anti-gene padlocks eliminate Escherichia coli based on their genotype.

Shi C, Parker AR, Hua L, Morrell CN, Lee SC, Bandaru V, Dumler JS, Wu TC, Eshleman JR. Shi C, et al. Among authors: parker ar. J Antimicrob Chemother. 2008 Feb;61(2):262-72. doi: 10.1093/jac/dkm482. Epub 2007 Dec 22. J Antimicrob Chemother. 2008. PMID: 18156610

8

A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents.

Parker AR, Leonard CP, Hua L, Francis RO, Dhara S, Maitra A, Eshleman JR. Parker AR, et al. Br J Cancer. 2004 Apr 19;90(8):1666-71. doi: 10.1038/sj.bjc.6601740. Br J Cancer. 2004. PMID: 15083201 Free PMC article.

9

8-Hydroxyguanosine repair is defective in some microsatellite stable colorectal cancer cells.

Parker AR, O'Meally RN, Oliver DH, Hua L, Nelson WG, DeWeese TL, Eshleman JR. Parker AR, et al. Cancer Res. 2002 Dec 15;62(24):7230-3. Cancer Res. 2002. PMID: 12499263

10

Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles.

Parker AR, O'Meally RN, Sahin F, Su GH, Racke FK, Nelson WG, DeWeese TL, Eshleman JR. Parker AR, et al. J Biol Chem. 2003 Nov 28;278(48):47937-45. doi: 10.1074/jbc.M306598200. Epub 2003 Sep 9. J Biol Chem. 2003. PMID: 12966098 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page